The effects of 5HT3 receptor antagonist granisetron on inflammatory parameters and angiogenesis in the air-pouch model of inflammation

International Immunopharmacology

Volumn 10, Issue 9, 2010, Pages 1010-1016

  Maleki Dizaji, Nasrin ^a   Eteraf Oskouei, Tahereh ^b   Fakhrjou, Ashraf ^c   Maljaie, Seyyed Hadi ^c   Garjani, Alireza ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Air pouch; Angiogenesis; Granisetron; Inflammation; Leukocyte

Indexed keywords

CARRAGEENAN; GRANISETRON; HEMOGLOBIN; PROSTAGLANDIN E2; SEROTONIN 3 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; SEROTONIN 3 ANTAGONIST;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; EXUDATE; GRANULOMA; INFLAMMATION; LEUKOCYTE; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; GRANULATION TISSUE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION; WISTAR RAT;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; DINOPROSTONE; GRANISETRON; GRANULATION TISSUE; INFLAMMATION; LEUKOCYTES; MALE; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, WISTAR; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955924845     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.05.013     Document Type: Article

References (53)

1. McDonald D.M. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001, 164(10):S39-S45.
2. Jackson J.R., Seed M.P., Kircher C.H., Willoughby D.A., Winkler J.D. The codependence of angiogenesis and chronic inflammation. FASEB J 1997, 11:457-465.
3. Colville-Nash P.R., Scott D.L. Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis 1992, 51:919-925.
4. Sueishi K., Yonemitsu Y., Nakagawa K., Kaneda Y., Kumamoto M., Nakashima Y. Atherosclerosis and angiogenesis: its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor. Ann NY Acad Sci 1997, 811:311-322.
5. Ishibashi T., Murata T., Kohno T., Ohnishi Y., Inomata H. Peripheral choriovitreal neovascularization in proliferative diabetic retinopathy: histopathologic and ultrastructural study. Ophthalmol 1999, 213:154-158.
6. Li V.W., Li W.W. Cyclosporine and angiogenesis in psoriasis. J Am Acad Dermatol 1996, 35:1019-1021.
7. Thurston G., Murphy T.J., Baluk P., Lindsey J.R., McDonald D.M. Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am J Pathol 1998, 153:1099-1112.
8. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31.
9. Serafeim A., Gordon J. The immune system gets nervous. Curr Opin Pharmacol 2001, 1:398-403.
10. Stefulj J., Jernej B., Cicin-Sain L., Rinner I., Schauenstein K. mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav Immun 2000, 14:219-224.
11. 1A receptor mRNA and protein in activated B and T lymphocytes. J Biol Chem 2001, 276:4382-4388.
12. 3A receptors in cells of the immune system. Scand J Rheumatol 2004, 33(3):9-11.
13. 3 receptor. Scand J Rheumatol 2004, 33(3):2-8.
14. 3 receptor network after 20years of research-evolving concepts in management of pain and inflammation. Eur J Pharmacol 2007, 560:1-8.
15. 3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone. Scand J Rheumatol Suppl 2004, 119:51-54.
16. 3 receptor antagonist tropisetron. Scand J Rheumatol Suppl 2004, 33:34-40.
17. 3 receptor antagonists in lipopolysaccharide-stimulated primary human monocytes. Scand J Rheumatol 2004, 33:1-5.
18. 2 and histamine of angiogenesis in inflammatory granulation tissue. Yakugaku Zasshi 2003, 123(5):295-303.
19. Sedgwick A.D., Sin Y.M., Edwards J.C.W., Willoughby D.A. Increased inflammatory reactivity in newly formed lining tissue. J Pathol 1983, 141:483-495.
20. Edward J.C.W., Sedgwick A.D., Willoughby D.A. The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J Pathol 1981, 134:147-156.
21. Clark I.A. How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev 2007, 18:335-343.
22. Kunkel S.L., Chensue S.W. Arachidonic acid metabolites regulate interleukin-1 production. Biochem Biophys Res Commun 1985, 128:892-897.
23. Spengler R.N., Spengler M.L., Strieter R.M., Remick D.G., Larrick J.W., Kunkel S.L. Modulation of tumor necrosis factor-a gene expression. Desensitization of prostaglandin E2-induced suppression. J Immunol 1989, 142:4346-4350.
24. Renz H., Gong J.H., Schmidt A., Nain M., Gemsa D. Release of tumor necrosis factor-a from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 1988, 141:2388-2393.
25. Gambero A., Becker T.L., Gurgueira S.A., Benvengo Y.H.B., Ribeiro M.L., Mendonca S., Pedrazzoli J. Acute inflammatory response induced by Helicobacter pylori in the rat air pouch. FEMS Immunol Med Microbiol 2003, 38:193-198.
26. Ghosh A.K., Hirasawa N., Ohtsu H. Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med 2002, 195(8):973-982.
27. Kimura M., Amemiya K., Yamada T., Suzuki J. Quantitative method for measuring adjuvant-induced granuloma angiogenesis in insulin-treated diabetic mice. J Pharmacobio-Dyn 1986, 9:442-446.
28. Colville-Nash P.R., Alam C.A.S., Brown J.R., Appleton I., Seed M.P., Willoughby D.A. The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. J Pharmacol Exp Ther 1995, 274:1463-1472.
29. Kowanko I.C., Gordon T.P., Rozenbilds M.A., Brooks P.M., Roberts-Thomson P.J. The subcutaneous air-pouch model of synovium and the inflammatory response to heat aggregated gammaglobulin. Agents Actions 1986, 18(3-4):421-428.
30. Romano M., Faggioni C.A.R., Sironi M., Sacco S., Echtenacher B., Di Santo E., et al. Carrageenan-induced acute inflammation in the mouse air pouch synovial model: role of tumour necrosis factor. Mediat Inflamm 1997, 6:32-38.
31. 2 release from macrophage-like synovial cells in serum-free tissue culture. Scand J Rheumatol 2004, 33:33.
32. Hrycaj P. Serotonin type 3 receptor antagonist tropisetron in the treatment of chronic inflammatory rheumatic conditions-preliminary clinical experience. Scand J Rheumatol 2004, 33(116):55-58.
33. Voog U., Alstergren P., Leibur E., Kallikorm R., Kopp S. Influence of serotonin on the analgesic effect of granisetron on temporomandibular joint arthritis. Mediat Inflamm 2004, 13:373-376.
34. 3 receptor antagonists in rheumatic diseases. Curr Top Med Chem 2006, 6(18):2035-2042.
35. García-Ramallo E., Marques T., Prats N., Beleta J., Kunkel S.L., Godessart N. Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation. J Immunol 2002, 169:6467-6473.
36. Zeitz K.P., Guy N., Malmberg A.B., Dirajlal S., Martin W.J., Linda Sun L., et al. The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002, 22(3):1010-1019.
37. Eschalier A., Kayser V., Guilbaud G. Influence of a specific 5-HT3 antagonist on carrageenan-induced hyperalgesia in rats. Pain 1989, 36:249-255.
38. Germonpre P.R., Joos G.F., Mekeirele K., Pauwels R.A. Role of the 5-HT receptor in neurogenic inflammation in Fisher 344 rat airways. Eur J Pharmacol 1997, 324:249-255.
39. Pierce P.A., Xie G.X., Peroutka S.J., Green P.G., Levine J.D. 5-Hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine2A receptors on sympathetic efferent terminals. J Pharmacol Exp Ther 1995, 275:502-508.
40. 2 levels. Br J Ophthalmol 1984, 68:656-659.
41. Barcelos L.S., Talvani A., Teixeira A.S., Vieira L.Q., Cassali G.D., Andrade S.P., et al. Impaired inflammatory angiogenesis, but not leukocyte influx, in mice lacking TNFR1. J Leukoc Biol 2005, 78:352-358.
42. Maleki N., Mohajjel Nayebi A., Garjani A. Effects of central and peripheral depletion of serotonergic system on carrageenan-induced paw edema. Int Immunopharmacol 2005, 5:1723-1730.
43. 3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells. Rheumatol Int 2008, 28(10):1017-1022.
44. Koch A.E. The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis 2000, 59(suppl I):i65-i71.
45. Ghosh A.K., Hirasawa N., Niki H., Ohuchi K. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats. J Pharmacol Exp Ther 2000, 295:802-809.
46. 1 and copper in angiogenesis. J Natl Cancer Inst 1982, 69:475-482.
47. 2 and angiogenesis. Proc Soc Exp Biol Med 1983, 172:214-218.
48. Arzt E., Costas M., Finkielman S., Nahmod V.E. Serotonin inhibition of tumor necrosis factor-alpha synthesis by human monocytes. Life Sci 1991, 48:2557-2562.
49. Kubera M., Kenis G., Bosmans E., Scharpe S., Maes M. Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10. Neuropsychopharmacology 2000, 23:89-98.
50. Vassiliou E., Jing H., Ganea D. Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells. Cell Immunol 2003, 223(2):120-132.
51. Idzko M., Panther E., Stratz C., Müller T., Bayer H., Zissel G., et al. The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol 2004, 172:6011-6019.
52. Ménard G., Turmel V., Bissonnette E.Y. Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2. Clin Exp Immunol 2007, 150:340-348.
53. Jenkinson L., Bardhan K.D., Atherton J., Kalia N. Helicobacter pylori prevents proliferative stage of angiogenesis in vitro role of cytokines. Dig Dis Sci 2002, 47(8):1857-1862.